These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

695 related items for PubMed ID: 16310900

  • 1. Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis.
    Sharma SK, Dube A, Nadeem A, Khan S, Saleem I, Garg R, Mohammad O.
    Vaccine; 2006 Mar 10; 24(11):1800-10. PubMed ID: 16310900
    [Abstract] [Full Text] [Related]

  • 2. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
    Mazumdar T, Anam K, Ali N.
    Vaccine; 2004 Mar 12; 22(9-10):1162-71. PubMed ID: 15003644
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Adjuvanticity and protective immunity of Plasmodium yoelii nigeriensis blood-stage soluble antigens encapsulated in fusogenic liposome.
    Dwivedi V, Vasco A, Vedi S, Dangi A, Arif K, Bhattacharya SM, Owais M.
    Vaccine; 2009 Jan 14; 27(3):473-82. PubMed ID: 18996429
    [Abstract] [Full Text] [Related]

  • 6. Comparison of liposome based antigen delivery systems for protection against Leishmania donovani.
    Bhowmick S, Mazumdar T, Sinha R, Ali N.
    J Control Release; 2010 Jan 25; 141(2):199-207. PubMed ID: 19818373
    [Abstract] [Full Text] [Related]

  • 7. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis.
    Oliveira-Freitas E, Casas CP, Borja-Cabrera GP, Santos FN, Nico D, Souza LO, Tinoco LW, da Silva BP, Palatnik M, Parente JP, Palatnik-de-Sousa CB.
    Vaccine; 2006 May 01; 24(18):3909-20. PubMed ID: 16556475
    [Abstract] [Full Text] [Related]

  • 8. Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multi-drug resistant isolate of Plasmodium yoelii nigeriensis in BALB/c mice.
    Sharma SK, Farah D, Misra-Bhattacharya S, Bajpai P, Agarwal A, Mohammad O.
    Vaccine; 2006 Feb 13; 24(7):948-56. PubMed ID: 16168527
    [Abstract] [Full Text] [Related]

  • 9. Enhanced efficacy and immunogenicity of 78kDa antigen formulated in various adjuvants against murine visceral leishmaniasis.
    Nagill R, Kaur S.
    Vaccine; 2010 May 21; 28(23):4002-12. PubMed ID: 20093205
    [Abstract] [Full Text] [Related]

  • 10. Non-coding pDNA bearing immunostimulatory sequences co-entrapped with leishmanial antigens in cationic liposomes elicits almost complete protection against experimental visceral leishmaniasis in BALB/c mice.
    Mazumder S, Ravindran R, Banerjee A, Ali N.
    Vaccine; 2007 Dec 17; 25(52):8771-81. PubMed ID: 18031874
    [Abstract] [Full Text] [Related]

  • 11. Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection.
    Tewary P, Pandya J, Mehta J, Sukumaran B, Madhubala R.
    FEMS Immunol Med Microbiol; 2004 Oct 01; 42(2):241-8. PubMed ID: 15364110
    [Abstract] [Full Text] [Related]

  • 12. Induction of partial protection against Leishmania donovani by promastigote antigens in negatively charged liposomes.
    Afrin F, Anam K, Ali N.
    J Parasitol; 2000 Aug 01; 86(4):730-5. PubMed ID: 10958448
    [Abstract] [Full Text] [Related]

  • 13. Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis.
    Tripathi P, Gupta SK, Sinha S, Sundar S, Dube A, Naik S.
    Scand J Immunol; 2008 Nov 01; 68(5):492-501. PubMed ID: 18803606
    [Abstract] [Full Text] [Related]

  • 14. Influence of phospholipid composition on the adjuvanticity and protective efficacy of liposome-encapsulated Leishmania donovani antigens.
    Mazumdar T, Anam K, Ali N.
    J Parasitol; 2005 Apr 01; 91(2):269-74. PubMed ID: 15986599
    [Abstract] [Full Text] [Related]

  • 15. Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.
    Garg R, Gupta SK, Tripathi P, Hajela K, Sundar S, Naik S, Dube A.
    Vaccine; 2006 Apr 05; 24(15):2900-9. PubMed ID: 16448729
    [Abstract] [Full Text] [Related]

  • 16. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
    Melby PC, Yang J, Zhao W, Perez LE, Cheng J.
    Infect Immun; 2001 Aug 05; 69(8):4719-25. PubMed ID: 11447143
    [Abstract] [Full Text] [Related]

  • 17. Leishmania donovani: identification of novel vaccine candidates using human reactive sera and cell lines.
    Arora SK, Pal NS, Mujtaba S.
    Exp Parasitol; 2005 Mar 05; 109(3):163-70. PubMed ID: 15713447
    [Abstract] [Full Text] [Related]

  • 18. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK, Naskar K, De T.
    Eur J Immunol; 2009 Aug 05; 39(8):2146-60. PubMed ID: 19593771
    [Abstract] [Full Text] [Related]

  • 19. Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response.
    Bhowmick S, Ravindran R, Ali N.
    Vaccine; 2007 Aug 29; 25(35):6544-56. PubMed ID: 17655984
    [Abstract] [Full Text] [Related]

  • 20. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.
    Infect Immun; 2009 Jan 29; 77(1):436-45. PubMed ID: 18981242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.